Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Santillan Reyes (CDMX, Mexico), V. Peláez Hernández (CDMX, Mexico), L. Martínez Bautista (CDMX, Mexico), K. Rosales Castillo (CDMX, Mexico), L. Luna Rodríguez (CDMX, Mexico), A. Orea Tejeda (CDMX, Mexico), C. Pineda Sánchez (CDMX, Mexico), M. Quintero Martínez (CDMX, Mexico), N. Martínez Luna (CDMX, Mexico), M. Gómez Martínez (CDMX, Mexico). PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 1026

Member's Comments

No comment yet.

Related content which might interest you: PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 RELATIONSHIP BETWEEN SIX-MINUTE WALK DISTANCE, PULMONARY FUNCTIONS AND PATIENT CENTERED OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018 PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 DEVELOPMENT OF A DIGITAL TELEREHABILITATION SOLUTION: ANALYSIS OF THE NEEDS OF PATIENTS WITH CHRONIC DISEASES Source: International Congress 2017 – Latest insights into chronic care Year: 2017 IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training Year: 2021 CORRELATION BETWEEN LUNG AND JOINT INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: CROSS SECTIONAL STUDY Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 QUALITY OF LIFE IN SMOKERS FOLLOWING SMOKING CESSATION TREATMENT Source: International Congress 2017 – Smoking cessation Year: 2017 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 UTILITY OF THE SIMPLIFIED PESI SCALE IN ELDERLY PATIENTS WITH ACUTE  SYMPTOMATIC PULMONARY THROMBOEMBOLISM Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021